Expression of P53 and Bcl-2 proteins in T-cell lymphoblastic lymphoma: Prognostic implications

Leukemia and Lymphoma

Volumn 43, Issue 2, 2002, Pages 333-337

  Naresh, K N ^a   Banavali, S D ^a   Bhatia, K G ^b   Magrath, I ^b   Soman, C S ^a   Advani, S H ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bcl 2; Lymphoblastic; Lymphoma; MCP 842; p53

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PROTEIN BCL 2; PROTEIN P53; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOBLASTOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; T CELL LYMPHOMA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LONGITUDINAL STUDIES; LYMPHOMA, LYMPHOBLASTIC; MALE; METHOTREXATE; NEOPLASM PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; VINCRISTINE;

EID: 0036197551     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819029000611610     Document Type: Article

References (24)

1. "Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India"
2. "Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: A report on 58 patients"
3. "Prognostic significance of p53 mutations in small non-cleaved cell lymphomas"
4. "p53 and bcl 2 expression in high grade B cell lymphomas: Correlation with survival time"
5. "Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line"
6. "Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma"
7. "Prognosis and treatment of lymphoblastic lymphoma in adults: A report on 80 patients"
8. "Adult lymphoblastic lymphoma: Clinical features and prognostic factors in 53 patients"
9. "The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations"
10. "Post thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations"
11. "p53 protein expression in leukemias"
12. "p53 expression and poor prognosis in childhood acute lymphoblastic leukemia"
13. "Molecular epidemiology of acute lymphoblastic leukemia in Egypt"
14. "Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood"
15. "Clinical significance of detecting p53 protein in Burkitt lymphoma and B-cell acute lymphoblastic leukemia using immunocytochemistry"
16. "Tumor suppressor gene alternation in adult acute lymphoblastic leukemia (ALL) Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL Oncology Group studies"
17. "Molecular mechanisms of drug resistance in tumours"
18. "Mutation is required to activate the p53 gene for cooperation with ras oncogene and transformation"
19. "p53: Oncogene or anti-oncogene?"
20. "Mutant p53-the commonest genetic abnormality in human cancer?"
21. "Genetic and immunohistochemical analysis in human breast cancer cell lines"
22. "Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia"
23. "BCL-2 expression does not correlate with patient outcome in pediatric acute myelogenous leukemia"
24. "Molecular mechanism of the t(14;18)-A model for lymphoid-specific chromosomal translocations"